Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 181 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, reported a transaction on March 6, 2024.
• Werner sold 181 shares of Twist Bioscience common stock at a price of $37.43 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Werner directly owns 43,680 shares of Twist Bioscience common stock.
• The sale was mandated by the issuer's equity incentive plans and does not represent discretionary trades by Werner.

Sentiment

Score: 7

Explanation: The sentiment is neutral. This is a routine transaction for tax purposes and doesn't indicate a change in the executive's outlook on the company.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest. It does not necessarily reflect a change in the executive's confidence in the company.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• Companies like Illumina (ILMN) and Thermo Fisher Scientific (TMO) also have similar equity compensation plans that result in executives periodically selling shares to cover taxes.
• The number of shares sold is relatively small compared to the total holdings, which is typical in these types of transactions.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a small sale related to tax obligations.

Key Dates